Athersys, Inc. Receives Orphan Drug D...

Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome

There are 2 comments on the BioSpace story from Jul 10, 2012, titled Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome. In it, BioSpace reports that:

Athersys, Inc. announced today that MultiStemA , Athersys' proprietary cell therapy, has been granted orphan drug designation by the U.S. Food and Drug Administration for the treatment of Hurler's Syndrome, also known as mucopolysaccharidosis type I or MPS-I. Hurler's Syndrome is a lysosomal storage disorder that affects approximately 1 of every ... (more)

Join the discussion below, or Read more at BioSpace.

athxer

Singapore, Singapore

#1 Jul 11, 2012
any idea when a partnership for this is happening??? Don;t wish to see another dilution exercise.
athxer

Singapore, Singapore

#2 Jul 17, 2012
I'm starting to loose patience at Athersys. Whenever there's slightest bit of positive news, this damn stock will go down and remain down.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News FDA clears drug for leading form of cystic fibr... Jul 3 Chloe Mica 1
News GSK reaches deal to manufacture HIV treatment i... Jul 2 Wessana Guedes 1
News Second Doctor Implicated In La Jolla Surgeon's ... (Apr '08) Jul 1 avoidthe biz 42
S.S.D. Chemical / Solution , CASTRO X OXIDE (Mar '12) Jun 30 Maria 14
News Vivus Drug Helps Men Get Erections in 30 Minute... (Nov '09) Jun 28 Empty 17
News A list of potential adverse reactions to the MM... Jun '15 MMR MAIMS KILLS 2
News CDC investigating error that caused live anthra... May '15 Jingler 1
More from around the web